Searched for
TRUMP PHARMA PLAN
Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest th...- GIFT Nifty rises 200 points, hints at a positive start for Dalal Street next weekIndian stocks might open higher next week. GIFT Nifty showed a strong rise Friday morning. Investors are watching oil prices and global eve...
- Metals, PSU banks drag markets down amid currency weakness and global uncertaintyIndian stocks and the rupee experienced a significant downturn on Thursday. Surging oil prices and rumors of potential military action agai...
- Markets rise as Iran crisis stays in limboIndian stock markets ended a three-day losing streak with a gain of 0.8 percent on Monday. This rise followed positive movements in Asian m...
- Silver and gold commodity based ETFs rally up to 3%. What should investors do?Silver and gold ETFs saw gains of up to 3% on Monday, despite a lower opening for bullion prices on MCX. Rising crude oil prices fueled inf...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Why stock market fell today? Sensex plunges 850 pts, Nifty below 24,200. 6 reasons behind selloffIndian equity benchmarks declined for a second straight session, pressured by a spike in crude oil prices, a weakening rupee and rising geo...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- Sun Pharma most exposed Indian company to Trump's new tariff threat, warns JefferiesIndian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...
- Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
- Trump administration targets deals in dozens of industries before midtermsThe Trump administration is aggressively pursuing deals across 20-30 critical industries, offering incentives like equity stakes and regula...
- US stocks futures move as Dow, S&P 500, Nasdaq fluctuate on Trump’s tariffs and PCE inflation dataUS stock futures moved up and down as traders watched new tariff news and waited for an inflation report. Some big companies like Intel, El...
- Pharma stocks decline amid Trump’s prescription drug price cuts announcementThe Nifty Pharma Index ended 0.2% higher Monday after tumbling almost 2.4% earlier in the day in response to Trump's remarks. The Sensex an...
- Pharma shares slip up to 3% as Trump order to boost U.S. drug manufacturing rattles Indian exportersIndian pharmaceutical stocks experienced a significant decline. This followed US President Donald Trump's executive order. The order aims t...
- No chill, just pills! Pharma stocks slide up to 8% as Trump does yes-no-yes on tariffShares of Indian pharma companies, including Aurobindo Pharma, Laurus Labs, IPCA Labs, and Lupin, fell up to 8% after U.S. President Donald...
- Dr. Reddy’s shares fall 6%, Aurobindo Pharma 10% as Trump signals 25% tariffs on pharma importsDr. Reddy’s Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest drugmaker, declined b...
- Pharma funds disappoint. Is it time to move out?The pharma funds have returned 0.37 per cent in one week, 2.33 per cent in one month, -0.98 per cent in three months and -3.48 per cent in ...
- Trump Effect: Stagger bets in IT, pharma funds to beat sector heat, advise analystsThe pharma fund category lost 5%, while the technology segment is down 3% in the past year, according to Morningstar. During the same perio...
- Stagger bets in IT, pharma funds to beat sector heat, advise analystsPharma funds have lost 5 per cent, while the IT segment is down 3% in the past year.
- US election: Mutual fund investors should stay focused on goalsIf they have spare cash, mutual fund investors can consider daily STP to benefit from the current market.
Load More
